Concepedia

Henry C. Marsh

HC

72

Publications

5.5K

Citations

39

H-Index

1975

Active since

Affiliations

Celldex Therapeutics (United States)(Current)

Oncotherapeutics (United States)

RTI International

University of North Carolina at Chapel Hill

One Cell Systems (United States)

Henry C. Marsh is an author at Celldex Therapeutics (United States) specializing in medicine, immunology, and complement system.

Top concepts

MedicineImmunologyCell BiologyComplement SystemImmunotherapyAutoimmunityBiochemistryPharmacologyNatural SciencesPhysiology

Publications per year

1975–2022

72

Publications

72

Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis

Harlan F. Weisman, Michelle K. Leppo, Henry C. Marsh et al. · Science · 1990 · 977 citations

Immunology, Immunologic Mechanism, Post-ischemic Myocardial Inflammation +17

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

Linda Hammerich, Thomas U. Marron, Ranjan Upadhyay et al. · Nature Medicine · 2019 · 423 citations

Vaccination, Tumor Immunology, Cancer Immunosurveillance +11

Neuronal Protection in Stroke by an sLe <sup>x</sup> -Glycosylated Complement Inhibitory Protein

Judy Huang, Louis J. Kim, Richard A. Mealey et al. · Science · 1999 · 314 citations

Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis

Charles W. Rittershaus, David P. Miller, Lawrence J. Thomas et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 311 citations

THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE REJECTION OF PORCINE XENOGRAFTS

Scott K. Pruitt, Allan D. Kirk, R. Randal Bollinger et al. · Transplantation · 1994 · 262 citations

Rows per page

1–5 of 72